Castle Harlan, Inc. (“Castle Harlan”), a Delaware corporation, is a private equity investment management firm founded in 1987 with offices in New York, New York; Naples, Florida; and Palm Beach, Florida. Castle Harlan is controlled by its principal owner, John K. Castle. Branford Castle Partners, L.P. (“Branford Castle”), a Delaware limited partnership, is a private equity investment management firm founded in 2015 (by a family office founded in 1986) with offices in New York, New York; Naples, Florida; Boca Raton, Florida; and Palm Beach, Florida. Branford Castle is controlled indirectly by its principal owner, John K. Castle. Castle Harlan BAF GP Corp. (“BAF GP Corp.”), a Delaware corporation, is a private equity investment management firm founded in 2023. BAF GP Corp. is controlled by John K. Castle, Patrick A. Zyla, and Eric M. Schwartz. Castle Harlan, Branford Castle, and BAF GP Corp. (each, an “Adviser” and collectively, the “Advisers”) serve as investment advisers with discretionary investment authority to private pooled investment vehicles and their associated parallel private investment vehicles (each, a “Fund” and collectively, the “Funds”), the securities of which are offered to investors on a private placement basis. Castle Harlan and BAF GP Corp., through their teams of approximately 8 and 3 investment professionals, respectively (the “Investment Professionals”), provide investment management services to the Funds relating to portfolio management and administrative services, including investigating, analyzing, structuring, and negotiating potential investments; monitoring the performance of portfolio companies; and advising the Funds as to disposition opportunities. On behalf of the Funds and their general partners, Castle Harlan and BAF GP Corp. seek to find investments in established middle market companies with strong market positions, stable cash flows, and strong achievable growth prospects. Castle Harlan and BAF GP Corp. exercise pricing discipline when evaluating investment opportunities and post- acquisition, manages the Funds’ portfolio companies through an operationally-focused approach that seeks to increase enterprise value. Castle Harlan and BAF GP Corp. source investments for their Funds in companies across many industries, with a particular emphasis on industrial, consumer and restaurant, and energy and chemicals, with enterprise values typically ranging from $100 million to $750 million and generally located in North America and Europe, although Castle Harlan and BAF GP Corp. have global investment sourcing capabilities. BAF GP Corp. has a stated intention to make acquisitions only of companies related to its existing business in the seafood industry. Branford Castle, through its team of approximately 6 Investment Professionals, provides investment management services to its Funds, including investigating, analyzing, structuring, and negotiating potential investments; monitoring the performance of portfolio companies; and advising the Funds as to disposition opportunities. On behalf of the Funds and their general partners, Branford Castle seeks to find investments in lower middle market companies with strong market positions, stable cash flows, and strong achievable growth prospects. Branford Castle sources investments for its Funds in companies across many industries, with a particular emphasis on (1) consumer goods and services; (2) industrial, manufacturing, and marine products and services; and (3) value-added commercial distribution and business services, with enterprise values typically ranging from $10 million to $75 million. The general partner of each Fund makes all investment and disposition decisions for the Fund. The partners of the general partners consist of Castle Harlan’s, BAF GP Corp.’s, or Branford Castle’s senior professionals and certain former professionals. As of the date hereof, the Funds managed by the Advisers, and their respective general partners include the following: Castle Harlan Funds 1. Castle Harlan Partners IV, L.P. (“CHP IV”) and its associated Funds; the general partner for CHP IV and its U.S. domiciled associated Funds, Castle Harlan Associates IV, L.P.; and the general partner to CHP IV’s offshore associated Fund, Castle Harlan Associates

IV, L.L.C. 2. Castle Harlan Partners V, L.P. (“CHP V”) and its associated Funds; and their general partner, Castle Harlan Associates V, L.P. 3. CHP V AIV Holdings L.P. (“CHP V AIV”) and its associated Funds; their general partner CHP V AIV GP Ltd.; and their special limited partner, CHP AIV SLP LP. 4. Castle Harlan SHC Partners, L.P. (“CH SHC”) and its general partner, Castle Harlan SHC GP, L.L.C. Branford Castle Funds 1. The Branford Castle Fund, L.P. (“BCF”) and its general partner, BC GP, LLC. 2. Titan Delaware Blocker, L.P. (“Titan Blocker”) and its general partner, BC GP, LLC. 3. The Branford Castle Fund II, L.P. (“BCF II”) and its general partner, Branford Castle Associates II, L.P. 4. Branford Top Hold Filtration Blocker, L.P. (“Filtration Blocker”) and its general partner, Branford Castle Associates II, L.P. 5. Branford Top Hold Lafayette Instrument Blocker, L.P. (“Lafayette Blocker”) and its general partner, Branford Castle Associates II, L.P. 6. Branford Top Hold Floats Blocker, L.P. (“Floats Blocker”) and its general partner, Branford Castle Associates II, L.P. 7. Branford Top Hold GPT Blocker, L.P. (“GPT Blocker”) and its general partner, Branford Castle Associates II, L.P. BAF GP Corp. Fund 1. Castle Harlan BAF Partners, L.P. (“CH BAF”) and its general partner and investment manager, BAF GP Corp. Notwithstanding any reference to services provided to the Fund or Funds, Castle Harlan is only the adviser to CHP IV and its associated Funds, CHP V and its associated Funds, CHP V AIV and its associated Funds, and CH SHC; Branford Castle is only the adviser to BCF, BCF II, Titan Blocker, Filtration Blocker, Lafayette Blocker, Floats Blocker, and GPT Blocker; and BAF GP Corp. is only the adviser to CH BAF. Throughout the remainder of this Brochure, the term “General Partner” is used to refer to each of the general partners described above. For the Funds managed by the Advisers, each Adviser’s investment management activities are generally related to seeking new investment opportunities, disposition opportunities, or, for certain of these Funds, follow-on investment opportunities for such Funds’ portfolio companies. The Commitment Period for BCF and its associated Funds closed on October 24, 2016; the Investment Period for BCF ended in September 2019, except for follow-on investments. The Commitment Period for BCF II closed on March 31, 2021, however by amendment approved by the limited partners this period was extended to June 7, 2021 for certain investors; the Investment Period for BCF II is open through March 31, 2026. The Commitment Period for CHP IV and its associated Funds closed on August 15, 2009, the Investment Periods for CHP V, CHP V AIV, and their associated funds closed on December 31, 2015. The Investment Period for CH SHC was open through July 31, 2022. The Commitment Period for CH BAF closed on October 31, 2023. The Advisers tailor their advisory services to the needs of the Funds in accordance with the limited partnership agreements and other governing documents of the Funds. Those documents specify the investments permitted to be made by the Funds and limit the types of securities that the Funds may acquire. The private offering memorandum of each Fund also specifies the types of investments that such Fund may pursue, and the Advisers advise on investments with respect to those specific investment types. The Advisers do not participate in wrap fee programs. As of December 31, 2023, the Advisers managed approximately $600,014,981 on a discretionary basis. This Brochure generally includes information about the Advisers and their relationships with their clients, which are their respective Funds and their affiliates. While much of this Brochure applies to all such Funds and affiliates, certain information included herein applies to specific Funds or affiliates only. This Brochure does not constitute an offer to sell or solicitation of an offer to buy any securities. The Advisers may offer any advisory services, engage in any investment strategy, and make any investment, including any not described in this Brochure, that they consider appropriate, subject to each Fund’s investment objectives and guidelines.